Drug Type Small molecule drug |
Synonyms SLV 334 |
Target |
Mechanism ECE inhibitors(Endothelin-converting enzyme 1 inhibitors), enkephalinase inhibitors(Neprilysin inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC33H36N2O6 |
InChIKeyLOFDNSDPZTVIIO-VPUSJEBWSA-N |
CAS Registry182821-33-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Injuries, Traumatic | Phase 2 | US | 01 Apr 2009 | |
Brain Injuries, Traumatic | Phase 2 | IL | 01 Apr 2009 | |
Brain Injuries, Traumatic | Phase 2 | IT | 01 Apr 2009 | |
Brain Injuries, Traumatic | Phase 2 | ES | 01 Apr 2009 | |
Brain Injuries | Phase 2 | - | - |